Trastuzumab-resistant breast cancer cells-derived tumor xenograft models exhibit distinct sensitivity to lapatinib treatment in vivo

被引：0
|
作者：
Hao Liu
Sanbao Ruan
Margaret E. Larsen
Congcong Tan
Bolin Liu
Hui Lyu
机构：
[1] Louisiana State University (LSU) Health Sciences Center,Departments of Interdisciplinary Oncology and Genetics, Stanley S. Scott Cancer Center, School of Medicine
[2] Affiliated Cancer Hospital & Institute of Guangzhou Medical University,undefined
来源：
Biological Procedures Online | / 25卷
关键词：
Therapeutic resistance; HER2-targeted therapy; In vivo tumor models; Breast cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Development of the CK-MB-1 trastuzumab-resistant HER2-positive breast cancer cell line and xenograft animal models
    Chung, Wei-Pang
    Huang, Wei-Lun
    Liao, Wei-An
    Huang, Wan-Ling
    Liu, You-Yu
    Su, Wu-Chou
    CANCER MEDICINE, 2021, 10 (07): : 2370 - 2379
  • [22] Long noncoding RNA expression profiling of tamoxifen-and trastuzumab-resistant breast cancer cells
    ZHANG Xiu-lei
    ZHU Tao
    WANG Xiang-ting
    中国病理生理杂志, 2015, (10) : 1835 - 1835
  • [23] Immunoconjugated gold nanoshell-mediated photothermal ablation of trastuzumab-resistant breast cancer cells
    Laura B. Carpin
    Lissett R. Bickford
    Germaine Agollah
    Tse-Kuan Yu
    Rachel Schiff
    Yi Li
    Rebekah A. Drezek
    Breast Cancer Research and Treatment, 2011, 125 : 27 - 34
  • [24] Immunoconjugated gold nanoshell-mediated photothermal ablation of trastuzumab-resistant breast cancer cells
    Carpin, Laura B.
    Bickford, Lissett R.
    Agollah, Germaine
    Yu, Tse-Kuan
    Schiff, Rachel
    Li, Yi
    Drezek, Rebekah A.
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 125 (01) : 27 - 34
  • [25] Cyclins contribute to MGB1-regulated aggressiveness of Trastuzumab-resistant breast cancer cells
    Ratih, Kusumastuti
    Kumagai, Yuji
    Ishihara, Seiichiro
    Haga, Hisashi
    CANCER SCIENCE, 2022, 113 : 982 - 982
  • [26] Concomitant Targeting of Tumor Cells and Induction of T-cell Response Synergizes to Effectively Inhibit Trastuzumab-Resistant Breast Cancer
    Wang, Qingfei
    Li, Shau-Hsuan
    Wang, Hai
    Xiao, Yi
    Sahin, Ozgur
    Brady, Samuel W.
    Li, Ping
    Ge, Hailiang
    Jaffee, Elizabeth M.
    Muller, William J.
    Hortobagyi, Gabriel N.
    Yu, Dihua
    CANCER RESEARCH, 2012, 72 (17) : 4417 - 4428
  • [27] Concomitant targeting of tumor cells and induction of T cell response synergizes to effectively inhibit trastuzumab-resistant breast cancer.
    Wang, Qingfei
    Li, Shau-Hsuan
    Wang, Hai
    Xiao, Yi
    Sahin, Ozgur
    Brady, Samuel W.
    Li, Ping
    Jaffee, Elizabeth M.
    Hortobagyi, Gabriel N.
    Yu, Dihua
    CANCER RESEARCH, 2013, 73 (08)
  • [28] Establishment and characterization of a unique circulating tumor cells-derived xenograft (CDX) in prostate cancer
    Faugeroux, Vincent
    Pailler, Emma
    Deas, Olivier
    Marty, Virginie
    Alexandrova, Kamelia
    Andree, Kiki
    Scoazec, Jean-Yves
    Stoecklein, Nikolas
    Manaresi, Nicolo
    Tramalloni, Dominique
    Ngo-Camus, Maud
    Nicotra, Claudio
    Terstappen, Leon
    Lapierre, Valerie
    Fizazi, Karim
    Loriot, Yohann
    Judde, Jean-Gabriel
    Farace, Francoise
    CANCER RESEARCH, 2018, 78 (13)
  • [29] Trastuzumab-Resistant HER2+ Breast Cancer Cells Retain Sensitivity to Poly (ADP-Ribose) Polymerase (PARP) Inhibition
    Wielgos, Monica E.
    Zhang, Zhuo
    Rajbhandari, Rajani
    Cooper, Tiffiny S.
    Zeng, Ling
    Forero, Andres
    Esteva, Francisco J.
    Osborne, C. Kent
    Schiff, Rachel
    LoBuglio, Albert F.
    Nozell, Susan E.
    Yang, Eddy S.
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (05) : 921 - 930
  • [30] Human breast tumor derived endothelial cells exhibit distinct biological properties
    Hegde, Mangala
    Bhat, Sharath Mohan
    Guruprasad, Kanive Parashiva
    Moka, Rajasekhar
    Ramachandra, Lingadakai
    Satyamoorthy, Kapaettu
    Joshi, Manjunath B.
    BIOLOGY OF THE CELL, 2022, 114 (02) : 73 - 85
12345